Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Despite improvements in surgical and radiotherapeutic techniques, a significant number of patients with locally advanced bladder cancer remain at a high risk of developing systemic disease. Jorge Garcia and Robert Dreicer discuss the conflicting evidence available for the use of neoadjuvant and adjuvant chemotherapy for bladder cancer.